My Library

University LibraryCatalogue

     
Limit search to items available for borrowing or consultation
Result Page: Previous Next
Can't find that book? Try BONUS+
 
Look for full text

Search Discovery

Search CARM Centre Catalogue

Search Trove

Add record to RefWorks

Cover Art
E-RESOURCE
Author Hiddemann, W.

Title New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia [electronic resource] / edited by W. Hiddemann, R. Mertelsmann.

Published Berlin, Heidelberg : Springer Berlin Heidelberg, 1990.

Copies

Location Call No. Status
 UniM INTERNET resource    AVAILABLE
Physical description 1 online resource (ix, 52 pages 3 illustrations)
Contents Aclarubicin in Single Agent and Combined Chemotherapy of Adult Acute Myeloid Leukemia -- Low-Dose Aclacinomycin and Intermediate-Dose Cytosine -- Arabinoside in Relapsed and Refractory Acute Myelogenous Leukemia -- Aclarubicin Plus Cytosine Arabinoside Versus Daunorubicin Plus Cytosine Arabinoside in De Novo Acute Myelocytic Leukemia: A Danish National Trial -- Fractionated Aclacinomycin in Combination with Cytosine Arabinoside and Etoposide for Remission Induction in Adult Acute Myeloid Leukemia -- Aclarubicin in the Treatment of Refractory Acute Leukemias -- Aclacinomycin A/Etoposide Combination Therapy for Advanced Relapsed Acute Myeloid Leukemia: Results of a Pilot Study of the Arbeitsgemeinschaft Internistische Onkologie -- Low-Dose Aclacinomycin A in Myelodysplastic Syndromes and Subsequent Acute Myelogenous Leukemia: A Phase II Study -- Sachverzeichnis.
Summary This book provides a unique overview of the current applications of aclacinomycin A in malignant hematologic disorders, as single-agent therapy or together with other agents in combination regimens. Accounts are given of its action in myelodysplastic syndromes and of its efficacy in acute myeloid leukemias for the latter, one chapter presents the results of single-agent therapy in older patients, while four other studies describe the efficacy of aclacinomycin A combined with conventional or intermediate-dose cytosine arabinoside or etoposide in relapsed or refractory acute myeloid leukemia.
Other author Mertelsmann, R.
Subject Medicine.
Hematology.
Oncology.
Electronic books.
ISBN 9783642757204 (electronic bk.)
3642757200 (electronic bk.)
9783540526131
3540526137